Small biotechs in the US that are thinking about expansion into Europe but face choosing between the UK and the EU as their base following Brexit are realizing that a home in Northern Ireland could give them the best of both worlds.
Northern Ireland Offers Biotechs Gateway To Both UK And EU
US Firms Weighing Up Attraction
Countries from all over the world were plying their wares as desirable biotech clusters at the recent BIO meeting in Boston and Northern Ireland made a strong case for its potential as a prime location for life sciences starts-ups.
More from Start-Ups & SMEs
More from Business
• By
Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.
• By
Plus deals involving Relmada/Trigone, Alvotech/Xbrane, OPKO Health/Entera, iOncologi/TargImmune and more.
• By
With its exon 53-skipping candidate already showing promise in 24-week data, Wave now has 48-week data showing improvements in muscle health and functional outcomes.